Transform Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$12M Sell
24,728
-172
-0.7% -$83.4K 0.73% 44
2024
Q4
$10M Buy
24,900
+891
+4% +$359K 0.56% 50
2024
Q3
$11.2M Buy
24,009
+530
+2% +$246K 0.74% 33
2024
Q2
$11M Buy
23,479
+390
+2% +$183K 0.83% 33
2024
Q1
$9.65M Buy
23,089
+762
+3% +$319K 0.92% 35
2023
Q4
$9.08M Buy
22,327
+308
+1% +$125K 0.89% 31
2023
Q3
$7.66M Buy
22,019
+85
+0.4% +$29.6K 0.81% 36
2023
Q2
$7.72M Sell
21,934
-190
-0.9% -$66.9K 0.69% 48
2023
Q1
$6.97M Sell
22,124
-102
-0.5% -$32.1K 0.66% 53
2022
Q4
$6.42M Buy
22,226
+5,530
+33% +$1.6M 0.72% 49
2022
Q3
$4.83M Buy
16,696
+1,499
+10% +$434K 0.63% 55
2022
Q2
$4.28M Buy
+15,197
New +$4.28M 0.64% 55
2021
Q2
Sell
-11,985
Closed -$2.58M 232
2021
Q1
$2.58M Buy
11,985
+871
+8% +$187K 0.52% 69
2020
Q4
$2.63M Buy
+11,114
New +$2.63M 0.55% 65